Dimension Capital II, L.P. has filed 3 insider transactions across 1 company since May 2026.
Most recent transaction: a transaction of 1709543 shares of Odyssey Therapeutics, Inc. ($ODTX) on May 08, 2026.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 8, 2026 | Odyssey Therapeutics, Inc. | $ODTX | Dimension Capital II, L.P. | Director | C | Common Stock | 1709543 | $0.00 | 2,222,405.0000 | 0 | 333.33% | 0.00% |
| May 8, 2026 | Odyssey Therapeutics, Inc. | $ODTX | Dimension Capital II, L.P. | Director | P | Common Stock | 1111111 | $18.00 | 3,333,516.0000 | 0 | 50.00% | 0.00% |
| May 8, 2026 | Odyssey Therapeutics, Inc. | $ODTX | Dimension Capital II, L.P. | Director | C | Series D Convertible Preferred Stock | 16611626 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |